View drug registration information details.
Items | Registration information |
ID | 520 |
No | 520 |
Brand Name | LEVOFLOXACIN KABI |
Ingredients | LEVOFLOXACIN HEMIHYDRATE EQ.TO LEVOFLOXACIN 500 MG/100 ML |
Dosage Form | SOLUTION FOR INFUSION |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 100 ML/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SOFT TISSUE INFECTION, ACUTE BACTERIAL SINUSITIS, ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS, CHRONIC BACTERIAL PROSTATITIS, PYELONEPHRITISAND COMPLICATED URINARY TRACT INFECTION, INHALATION ANTHRAX |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | TRANSPARENT SOLUTION WITH PALE YELLOWISH, CONTAINED IN 100 ML SEALED TRANSPARENT NEUTRAL GLASS BOTTLE |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | FRESENIUS KABI VIETNAM JOINT STOCK COMPANY |
Country | VIETNAM |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 I 5467/23 |
FDD Registration Date | 11-APR-2023 |
Expiry Date | 10-APR-2026 |
Back to drug list
|